Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals

Table 4 Metabolites with significant difference among groups during the validation stage

Metabolites (umol/L)	NM	MUCO	MHPO	P2
Leucine	189.5 ± 37.6	321.5 ± 36.8	216.6 ± 32.6	0.346
Isoleucine	87.7 ± 48.2	132.0 ± 52.7	92.5 ± 45.2	0.584
Valine	297.8 ± 50.1	388.5 ± 53.4	291.3 ± 43.4	0.917
alphaAAA	2.45 ± 0.24	3.10 ± 0.40	2.62 ± 0.29	0.138
C3	0.30 ± 0.08	0.42 ± 0.11	0.29 ± 0.11	0.976

All values are means ± SDs. The One-Way ANOVA followed by Tukey test was set to p < 0.05. NW normal weight, MUCO metabolically unhealthy central obesity, MHPO metabolically healthy peripheral obesity; alphaAAA, alpha-aminoadipic acid. Logarithmic transformation was used for the variables that did not have normal distribution (alphaAAA); P1: The P value between MUCO and NW groups; P2: The P value between MHPO and NW groups; P3:The P value between MUPO and MHPO groups

ISSN: 1743-7075